Bupa 'first' claim met with scepticism
Rival private medical insurance providers have expressed surprise at Bupa’s claim to have secured an industry first in its cancer cover limits.
The healthcare giant recently completed a dramatic U-turn by declaring it would cease to cap cancer cover for its corporate schemes after finding that capping cancer left patients, who claimed on their policies, vulnerable at critical points in their treatment.
However, Alistair Sclare, healthcare director at Groupama Healthcare said that there was nothing new about the approach.
“It is not correct to say that most insurers are capping cancer cover with overall cost or time limits, although it
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.
You are currently unable to print this content. Please contact info@insuranceage.co.uk to find out more.
You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Most read
- Zurich strikes five-year capacity deal with MGA Freedom Services
- Pen inks £150m social housing capacity deal with SiriusPoint
- RSA and NIG brands to become one next year but undecided on name